Literature DB >> 163886

The influence of intracellular levels of cyclic nucleotides on cell proliferation and the induction of antibody synthesis.

J Watson.   

Abstract

The intracellular ratio of adenosine 3',5'-cyclic monophosphate (cyclic AMP) to guanosine 3',5'-cyclic monophosphate (cyclic GMP) may control the developmental pathway followed by antibody-forming cell (AFC) precursors. The evidence for this is derived from several different types of experiments. First lipopolysaccharide (LPS) which is mitogenic for B lymphocytes, stimulates rapid, transient changes in intracellular levels of cyclic GMP but not cyclic AMP when added to mouse spleen cultures. Cyclic GMP itself stimulates DNA synthesis in these cultures, suggesting that the intracellular changes in cyclic GMP levels are involved in the mitogenic signal delivered by LPS to cells. The absolute amounts of cyclic nucleotides may vary widely in different cells under various conditions, however, the intracellular ratio of cyclic AMP to cyclic GMP is always high in nondividing cells and low in dividing cells. AFC precursors appear to respond to antigen in the absence of T-cell activity by inactivation (1-7). In the response to antigen in the presence of specific T cells, precursor cells proliferate and mature to AFC. Raising intracellular levels of cyclic AMP inhibits cell proliferation and leads to precursor cell inactivation (14, 15). It is suggested that the interaction of antigen with immunoglobulin receptors on the surface of precursors cells leads to the stimulation of adenylate cyclase activity and initiates the inactivation pathway. Since cyclic GMP stimulates immune responses in T-cell-depleted cultures (14, 15) and increasing cyclic GMP levels appear to be involved in the delivery of a mitogenic signal to cells, it is suggested that T-helper cells deliver a signal to precursor cells via the stimulation of guanylate cyclase to initiate the inductive pathway. It is suggested that it is the intracellular ratio of cyclic AMP to cyclic GMP that regulates the fate of precursor cells, not the absolute level of one cyclic nucleotide.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 163886      PMCID: PMC2190497          DOI: 10.1084/jem.141.1.97

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  31 in total

1.  B cell mitogenic properties of thymus-independent antigens.

Authors:  A Coutinho; G Möller
Journal:  Nat New Biol       Date:  1973-09-05

2.  Enhancement by purine nucleosides and nucleotides of serum-induced DNA synthesis in quiescent 3T3 cells.

Authors:  S Schor; E Rozengurt
Journal:  J Cell Physiol       Date:  1973-06       Impact factor: 6.384

3.  Carrier function in anti-hapten antibody responses. 3. Stimulation of antibody synthesis and facilitation of hapten-specific secondary antibody responses by graft-versus-host reactions.

Authors:  D H Katz; W E Paul; E A Goidl; B Benacerraf
Journal:  J Exp Med       Date:  1971-02-01       Impact factor: 14.307

4.  The use of allogeneic T lymphocytes and bacterial lipopolysaccharide to induce immune responses to monovalent haptens in vitro.

Authors:  E Trenkner
Journal:  J Immunol       Date:  1974-09       Impact factor: 5.422

5.  Induction of a primary antihapten response in vivo by a graft-vs.-host reaction.

Authors:  J A Hamilton; J F Miller
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

6.  Immunity tolerance to a hapten (NIP) coupled to an isologous carrier (mouse gamma globulin).

Authors:  C S Walters; J W Moorhead; H N Claman
Journal:  J Exp Med       Date:  1972-09-01       Impact factor: 14.307

7.  Immunological tolerance in bone marrow-derived lymphocytes. 3. Tolerance induction in primed B cells by hapten conjugates of unrelated immunogenic or "nonimmunogenic" carriers.

Authors:  D H Katz; T Hamaoka; B Benacerraf
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

8.  Mechanism of thymus-independent immunocyte triggering. Mitogenic activation of B cells results in specific immune responses.

Authors:  A Coutinho; E Gronowicz; W W Bullock; G Möller
Journal:  J Exp Med       Date:  1974-01-01       Impact factor: 14.307

9.  The behavior of hapten-poly-L-lysine conjugates as complete antigens in genetic responder and as haptens in nonresponder guinea pigs.

Authors:  I Green; W E Paul; B Benacerraf
Journal:  J Exp Med       Date:  1966-05-01       Impact factor: 14.307

10.  Termination of tolerance to human gamma globulin in mice by antigen and bacterial lipopolysaccharide (endotoxin).

Authors:  J M Chiller; W O Weigle
Journal:  J Exp Med       Date:  1973-03-01       Impact factor: 14.307

View more
  29 in total

1.  Regulation of guanylate and adenylate cyclase activities by lysolecithin.

Authors:  W T Shier; J H Baldwin; M Nilsen-Hamilton; R T Hamilton; N M Thanassi
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

2.  The lymphocyte plasma membrane: locus of control in the immune response.

Authors:  L M Jerry; A K Sullivan
Journal:  In Vitro       Date:  1976-03

3.  Two distinct lumphocyte-stimulating soluble factors (LAF) released from murine peritoneal cells. I. The cellular source and the effect of cGMP on their release.

Authors:  T Diamantstein; A Ulmer
Journal:  Immunology       Date:  1976-05       Impact factor: 7.397

4.  Alteration of cellular adhesion by nerve growth factor.

Authors:  D Schubert; C Whitlock
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

5.  Phenotypic transformation of clonal myogenic cells to cells resembling chondrocytes.

Authors:  D Schubert; M Lacorbiere
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

6.  Myocardial degeneration in mice treated with dibutyryl cyclic AMP and/or theophylline.

Authors:  P Ebbesen
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-12-07

7.  Intracellular contents of cyclic nucleotides in neutrophils and lymphocytes from patients with systemic lupus erythematosus.

Authors:  M Shingu; K Tatsukawa; M Nobunaga
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

Review 8.  Immunocompetent cells in resistance to bacterial infections.

Authors:  P A Campbell
Journal:  Bacteriol Rev       Date:  1976-06

9.  Low beta-adrenergic receptor concentration on human thymocytes.

Authors:  R J van de Griend; A Astaldi; P Wijermans; R van Doorn; D Roos
Journal:  Clin Exp Immunol       Date:  1983-01       Impact factor: 4.330

10.  Intercellular immunological controls and modulation of cyclic AMP levels. Some doubts.

Authors:  M C Berenbaum; E C Purves; I E Addison
Journal:  Immunology       Date:  1976-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.